What is the prevalence of Potocki-Lupski syndrome?

Potocki-Lupski syndrome (PTLS) is an ultra-rare genetic condition with an estimated prevalence of approximately 1 in 25,000 to 1 in 100,000 individuals. Because many cases are likely undiagnosed or misdiagnosed due to the wide variability of clinical presentation, these prevalence figures are considered estimates rather than precise population counts.

What is the estimated prevalence and incidence of Potocki-Lupski syndrome?

Potocki-Lupski syndrome is classified as an ultra-rare chromosomal disorder caused by a duplication of a small piece of chromosome 17 (specifically 17p11.2). While exact global incidence rates are difficult to establish, clinical literature commonly cites a prevalence range between 1 in 25,000 and 1 in 100,000. It is important to note that these numbers are based on reported clinical cases; the true prevalence of Potocki-Lupski syndrome may be higher, as mild presentations often go undetected by current diagnostic screening tools.

Does Potocki-Lupski syndrome affect genders or ethnicities differently?

Current clinical data does not suggest a significant difference in the prevalence of Potocki-Lupski syndrome between males and females; it appears to affect both genders equally. Furthermore, there is no evidence to suggest that Potocki-Lupski syndrome is more common in any specific ethnic or geographic population. Because the condition arises from a spontaneous (de novo) genetic duplication during reproductive cell formation, it occurs sporadically across all human populations regardless of ancestry.

What are the challenges in determining accurate prevalence data?

Determining the exact number of people living with Potocki-Lupski syndrome is hindered by several factors:

• Diagnostic Complexity: The symptoms of Potocki-Lupski syndrome, which include developmental delays, autism spectrum disorder, and cardiac anomalies, often overlap with other genetic conditions, leading to initial misdiagnosis.


• Variable Expressivity: The clinical severity of Potocki-Lupski syndrome varies greatly between individuals, meaning some cases are so mild they never come to the attention of geneticists.


• Access to Testing: Access to chromosomal microarray analysis (CMA), the gold standard for diagnosing Potocki-Lupski syndrome, is not uniform globally, creating gaps in data collection.

How does the DiseaseMaps community compare to clinical estimates?

While formal medical databases provide the broad epidemiological picture, real-world data from the DiseaseMaps.org community offers a unique perspective. Currently, 14 people with Potocki-Lupski syndrome have joined the DiseaseMaps.org platform to share their experiences. While this number does not represent the global population, these community-reported cases are vital for researchers to better understand the lived experience and common diagnostic pathways of those affected by Potocki-Lupski syndrome.

Next steps

• Consult with a clinical geneticist to discuss genetic testing if you suspect Potocki-Lupski syndrome.


• Connect with the Potocki-Lupski syndrome community on DiseaseMaps.org to share resources and experiences with other families.


• Review your medical records with a specialist to ensure that all neurodevelopmental and cardiac symptoms are being monitored appropriately.


• Keep up to date with the latest research through the NIH Genetic and Rare Diseases (GARD) Information Center.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Potocki-Lupski syndrome overview.


• Orphanet: Rare disease database entry for 17p11.2 duplication syndrome.


• OMIM (Online Mendelian Inheritance in Man): Potocki-Lupski syndrome entry #610883.


• PubMed: Current clinical research literature on the phenotypic spectrum of 17p11.2 duplication.